John B Stanchfield, MD | |
1160 East 3900 South, Suite 1200, Salt Lake City, UT 84124 | |
(801) 261-9651 | |
(801) 261-9656 |
Full Name | John B Stanchfield |
---|---|
Gender | Male |
Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
Location | 1160 East 3900 South, Salt Lake City, Utah |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134147226 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 152561-8905 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
John B Stanchfield, MD 1160 East 3900 South, Suite 1200, Salt Lake City, UT 84124 Ph: (801) 261-9651 | John B Stanchfield, MD 1160 East 3900 South, Suite 1200, Salt Lake City, UT 84124 Ph: (801) 261-9651 |
News Archive
Nurses sleep nearly an hour and a half less before work days compared to days off, which hurts patient care and safety, finds a new study by researchers at NYU Rory Meyers College of Nursing. The findings are published in Sleep Health, the journal of the National Sleep Foundation.
Rush University Medical Center is participating in a new clinical trial to test the effectiveness of the drug remdesivir in the treatment of coronavirus disease 2019 (COVID-19). This disease currently has no approved treatment.
Due to disease-related changes in their brain, pain patients often suffer from an impaired tactile ability in their hands. In a pilot study conducted by scientists at the Ruhr-University Bochum, high frequency repetitive stimulation was investigated as a therapeutic approach for these patients.
Patients with first-episode psychosis and comorbid cannabis abuse are at high risk for poor symptom control even when on medication, suggest findings published in Schizophrenia Research.
Cyclooxygenase-2 represents a key modulatory molecule in inflammation and carcinogenesis. COX-2 is known to have multiple tumorigenic effects. Increased expression of COX-2 has been observed in a variety of tumors including pancreatic cancer.
› Verified 4 days ago
Dr. Mehmet Akkaya, M.D Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: University Of Utah Hospital Cardiology, 3o N,1900 E, Rm:4a100, Salt Lake City, UT 84132 Phone: 801-505-1689 | |
Dr. Willard Dere, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 500 Foothill Blvd, Salt Lake City, UT 84148 Phone: 801-582-1565 | |
Megan Meier, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Joel Money, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Mchale O. Anderson, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4a100, Salt Lake City, UT 84132 Phone: 801-587-2451 | |
Siddharth K. Iyengar, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4c116, Salt Lake City, UT 84132 Phone: 801-581-7606 | |
Taryn A. Young, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 5121 S Cottonwood St, Salt Lake City, UT 84107 Phone: 801-507-4384 Fax: 801-507-4398 |